Free Trial

Boston Partners Sells 212,386 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Boston Partners trimmed its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 23.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 695,705 shares of the company's stock after selling 212,386 shares during the quarter. Boston Partners owned about 1.19% of Molina Healthcare worth $251,379,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in MOH. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in Molina Healthcare during the third quarter valued at approximately $30,000. McIlrath & Eck LLC purchased a new position in Molina Healthcare during the fourth quarter worth $34,000. VisionPoint Advisory Group LLC raised its stake in shares of Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company's stock valued at $36,000 after acquiring an additional 57 shares during the period. Principal Securities Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter worth about $42,000. Finally, Friedenthal Financial purchased a new position in shares of Molina Healthcare during the 4th quarter worth about $43,000. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Stock Down 0.6 %

Shares of MOH traded down $2.25 during mid-day trading on Monday, hitting $352.35. The company's stock had a trading volume of 373,719 shares, compared to its average volume of 398,846. The firm has a market capitalization of $20.65 billion, a price-to-earnings ratio of 19.12, a PEG ratio of 1.09 and a beta of 0.54. The company's 50-day moving average is $378.61 and its 200-day moving average is $372.27. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare, Inc. has a 52-week low of $266.35 and a 52-week high of $423.92.


Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.46 by $0.27. The company had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. Molina Healthcare's revenue was up 21.9% compared to the same quarter last year. During the same period last year, the company posted $5.81 earnings per share. On average, equities research analysts forecast that Molina Healthcare, Inc. will post 23.59 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the transaction, the director now directly owns 11,207 shares of the company's stock, valued at $4,494,567.35. The sale was disclosed in a filing with the SEC, which is accessible through this link. 1.10% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on MOH shares. Cantor Fitzgerald reissued an "overweight" rating and issued a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, April 4th. TD Cowen dropped their price objective on Molina Healthcare from $453.00 to $412.00 and set a "buy" rating for the company in a report on Tuesday, April 30th. Bank of America lowered Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 target price on the stock. in a research note on Thursday, March 28th. Stephens reissued an "equal weight" rating and set a $390.00 target price on shares of Molina Healthcare in a research note on Thursday, April 25th. Finally, Truist Financial raised their price target on shares of Molina Healthcare from $435.00 to $460.00 and gave the stock a "buy" rating in a research note on Tuesday, February 20th. One analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, Molina Healthcare currently has an average rating of "Hold" and a consensus price target of $404.90.

View Our Latest Stock Analysis on MOH

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Stories

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH - Free Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Molina Healthcare right now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: